Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Jul 29 2022

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE · · 2 pages · English

On 6ix: 6ix.com/news/press-release-jul-29-2022-7

Watch Glenmark Pharmaceuticals' latest callGlenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call · Replay · Nov 6

Release

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 29-Jul-2022 titled Glenmark Pharmaceuticals receives ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules, 1 mg/20 mcg

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases